Many who suffer from Type 1 diabetes rely on an insulin pump to deliver the insulin they need to manage their disease. The failure of these devices can be catastrophic. For example, a malfunction that results in a misdosing of insulin can result in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar). Hypoglycemia symptoms include dizziness and disorientation, and severe hyperglycemia can ultimately lead to loss of consciousness, seizures, and even death. These risks make the recent recall of certain Medtronic insulin pumps especially alarming.
On February 12, 2020, the FDA issued a notice that Medtronic is recalling over 300,000 insulin pumps distributed between September 2006 and October 2019. According to the recall, the Medtronic MiniMed 600 Series Insulin Pumps can under- or over-deliver insulin due to a missing or damaged retainer ring. A missing or damaged retainer ring can prevent the insulin cartridge from locking into the pump itself, which can interrupt the amount of insulin being delivered to the patient and lead to the aforementioned dangers. Indeed, Medtronic is aware of at least 2,175 injuries and one death linked to its 600 Series Insulin Pumps malfunctioning. In response, Medtronic issued a November 2019 safety notification letter urging its patients to routinely inspect their pumps for a missing or damaged retainer ring. The failure to do so could prove fatal.
If you or a loved one has suffered injuries that you suspect could be attributed to a Medtronic MiniMed insulin pump, contact one of the experienced dangerous drug and medical device attorneys at Burg Simpson’s Cincinnati office today. Our award-winning lawyers possess the knowledge and resources to investigate your potential claim and fight dangerous device manufacturers that refuse to take responsibility for the harm they cause. Call 1-513-852-5600 or fill out our contact form for a FREE no-obligation consultation today.